Controversies in dyspepsia

European Journal of Surgery, Supplement

Volumn 167, Issue 586, 2001, Pages 4-11

  Berstad, A ^a   Olafsson, S ^a   Tefera, S ^a   Hatlebakk, J G ^a   Gilja, O H ^a   Hausken, T ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Functional dyspepsia; Gastric accommodation; Gastro oesopahgeal reflux disease; Psychological factors; Vagal nerve activity; Visceral hypersensitivity

Indexed keywords

ANTACID AGENT; BUSPIRONE; CISAPRIDE; GLUCAGON; GLYCERYL TRINITRATE; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; SUMATRIPTAN;

ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL TRIAL; DRUG EFFECT; DYSPEPSIA; ERADICATION THERAPY; FUNCTIONAL DISEASE; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; MEAL; MENTAL DISEASE; MODEL; PATHOGENESIS; PRIORITY JOURNAL; QUALITY OF LIFE; SMOOTH MUSCLE RELAXATION; STOMACH ACID; SYMPTOM; TREATMENT OUTCOME; VAGUS TONE; HELICOBACTER INFECTION; PATHOPHYSIOLOGY; REVIEW;

DYSPEPSIA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 0034740535     PISSN: 1102416X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. American gastroenterological association medical position statement: Evaluation of Dyspepsia
2. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesphagitis after treatment with lansoprazole
3. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia
4. Visceral perception in health and functional dyspepsia
5. GERD: Management algorithms for the primary care physician and the specialist
6. Abnormal cardiovascular reflexes in patients with gastro-oesophageal reflex
7. Relations among autonomic nerve dysfunction, oesophageal motility, and gastric emptying in gastro-oesophageal reflux disease
8. Disease management in ulcer disease
9. Helicobacter pylori and reflux disease
10. The appearance of GORD in patients with duodenal ulcer after eradication of Helicobacter pylori (Hp) infection: A 4 year prospective study
11. Inhibition of gastric acid secretion by stress: A protective reflex mediated by cerebral nitric oxide
12. Are frequent short gastro-oesophageal reflux episodes the cause of symptoms in patients with non-ulcer dyspepsia responding to treatment with ranitidine?
13. Ranitidine effectively relieves symptoms in a subgroup of patients with functional dyspepsia
14. Impaired accomodation of proximal stomach to a meal in functional dyspepsia
15. Effect of glyceryl trinitrate on gastric accomodation and symptoms in functional dyspepsia
16. High incidence of reflux esophagitis after the eradication therapy of Helicobacter pylori: Impact of role of hiatus hernia and corpus gastritis
17. Abnormal gastric adaptive relaxation in patients with gastrooesophageal reflux
18. Heartburn treatment in primary care: Randomised, double blind study for 8 weeks
19. Low vagal activity as mediating mechanism for the relationship between personality factors and gastric symptoms in functional dyspepsia
20. Psychological factors and somatic symptoms in functional dyspepsia. A comparison with duodenal ulcer and healthy controls
21. What are the real problems for patients with functional dyspepsia
22. Wide gastric antrum in patients with non-ulcer dyspepsia. Effect of cisapride
23. Low vagal tone and antral dysmotility in patients with functional dyspepsia
24. Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis
25. The effect of cimetidine in non-ulcer dyspepsia
26. The predictive value of history in dyspepsia
27. Long-term survey of symptoms, lesion(s) and quality of life after HP eradication: Disappointing results of a follow-up questionnaire
28. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication
29. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis
30. Abdominal visceral receptors
31. Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia
32. Does cure of Helicobacter pylori infection induce heartburn?
33. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia
34. The origin of symptoms on the brain-gut axis in functional dyspepsia
35. Clinical spectrum of gastroesophageal reflux disease after HP eradication in patients with duodenal ulcer
36. Transient lower oesophageal sphincter relaxation
37. Gastric tone determines the sensitivity of the stomach to distention
38. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia
39. Prevalence of gastro-oesophageal reflux disease (GORD) in H. pylori-positive peptic ulcer disease and the impact of eradication therapy
40. Impairment of vagal function in reflux oesophagitis
41. Spiramycin is comparable to oxytetracycline in eradicating H. pylori when given with ranitidine bismuth citrate and metronidazole
42. Motor function of the proximal stomach and visceral perception in gastrooesophageal reflux disease
43. Cardiac vagal tone: A physiological index of stress
44. Orienting in a defensive world: Mammalian modifications of our evolutionary heritage. A polyvagal theory
45. Responses to gastric distension in functional dyspepsia
46. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients
47. Studies of patients with atrophic gastritis: A 10-15 year follow-up
48. Role of impaired gastric accommodation to a meal in functional dyspepsia
49. Actions of the 5-hydroxytryptamine 1 receptor agonist sumatriptan on interdigestive gastrointestinal motility in man
50. A placebo-controlled trial of buspirone, a fundus-relaxing drug, in functional dyspepsia: Effect on symptoms and gastric sensory and motor function
51. Efficacy of omeprazole in functional dyspepsia: Double-blind, randomized, placebo-controlled trials (the Bond and Opera studies)
52. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia
53. Eradication of Helicobacter pylori in functional dyspepsia: Randomized double blind placebo controlled trial with 12 months' follow up
54. The effect of Helicobacter pylori eradication on gastro-oesophageal reflux
55. Gastric accommodation in patients with gastro-oesophageal reflux disease
56. Completely opposite gastric accommodation patterns in functional dyspepsia and reflux oesophagitis
57. Current European concepts in management of Helicobacter pylori infection. The Maastricht Consensus Report
58. The role of Helicobacter pylori infection in non-ulcer dyspepsia
59. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis
60. Discriminant analysis of factors distinguishing patients with functional dyspepsia from patients with duodenal ulcer. Significance of somatization
61. Influence of a 5HT1 receptor agonist on gastric accommodation and initial transpyloric flow in healthy subjects
62. Motor and sensory function of the proximal stomach in reflux disease and after laparoscopic Nissen fundoplication
63. Proximal gastric tone in gastro-oesophageal reflux disease